Consensus NeuroBo Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
3.78 ^USD	+1.34%		+20.38%	+2.26%

17/04	Sector Update: Health Care Stocks Mixed Wednesday Afternoon	MT
17/04	NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise	MT

e093.g9mxiVS24OJupwhUScuZdMVWuWj96_gRAp0tAWU4rh8.z4vZwRzfgbE68DoNDqroM5EU8RytrsFpVK5_N1RJ-n3XgebaNYSugEPUUQ~ece593000929998dcacc7e8510f7d26e

Ladenburn Thalmann Starts NeuroBo Pharmaceuticals at Buy With $6 Price Target	07/22/07	MT
NEUROBO PHARMACEUTICALS : HC Wainwright Adjusts Price Target on NeuroBo Pharmaceuticals to $16 From $20, Reiterates Buy Rating	01/21/01	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.78 USD

Average target price

36.5 USD

Spread / Average Target

+865.61%

High Price Target

48 USD

Spread / Highest target

+1,169.84%

Low Price Target

25 USD

Spread / Lowest Target

+561.38%

Ladenburg Thalmann
HC Wainwright